AstraZeneca Pharma India Limited announced unaudited earnings results for the first quarter ended June 30, 2018. For the quarter, the company’s revenue from operations was INR 1,614.368 million compared to INR 1,284.658 million a year ago. Total revenue was INR 1,648.596 million compared to INR 1,331.199 million a year ago. Profit before exceptional and extraordinary items and tax was INR 91.519 million compared to INR 71.630 million a year ago. Profit before tax was INR 91.519 million compared to INR 71.630 million a year ago. Profit for the period was INR 63.934 million compared to INR 57.973 million a year ago. Earnings per share-basic and diluted were INR 2.56 compared to INR 2.32 a year ago.